Guala Closures S.p.A.:企業の戦略・SWOT・財務情報

◆英語タイトル:Guala Closures S.p.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6901
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:紙・包装
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Guala Closures S.p.A. – Strategy, SWOT and Corporate Finance Report
Summary

Guala Closures S.p.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Guala Closures S.p.A. (Guala Closures), a subsidiary of GCL Holdings S.C.A., is a packaging company. It designs, manufactures, and markets non-refillable closures. The company’s product portfolio comprises safety closures, tamper-evident systems, non-refillable closures, and capping systems. It also offers safety closures, decorative closures, wine closures, pharma closures, and aluminum closures. The company manufactures poly ethylene terephthalate (PET) products such as bottles, jars, molds, containers, flasks, and miniatures. Guala Closures serves diverse industries, which include food and beverages, cosmeceutical, and pharmaceutical markets. The company operates manufacturing facilities in India, Poland, the UK, Australia, Spain, Ukraine, Mexico, South Africa, and Argentina. Guala Closures is headquartered in Spinetta Marengo, Alessandria, Italy.

Scope

- Detailed information on Guala Closures S.p.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Guala Closures S.p.A. in the form of a SWOT analysis
- An in-depth view of the business model of Guala Closures S.p.A. including a breakdown and examination of key business segments
- Intelligence on Guala Closures S.p.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Guala Closures S.p.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Guala Closures S.p.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Guala Closures S.p.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Guala Closures S.p.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Guala Closures S.p.A.: Company Overview 9
Guala Closures S.p.A.: Overview and Key Facts 9
Guala Closures S.p.A.: Overview 9
Guala Closures S.p.A.: Key Facts 9
Guala Closures S.p.A.: Key Employees 10
Guala Closures S.p.A.: Major Products and Services 11
Guala Closures S.p.A.: Company History 12
Guala Closures S.p.A.: Management Statement 15
Guala Closures S.p.A.: Locations and Subsidiaries 16
Guala Closures S.p.A.: Key Competitors 18
Guala Closures S.p.A.: Company Analysis 19
Guala Closures S.p.A.: Business Description 19
Guala Closures S.p.A.: SWOT Analysis 22
Guala Closures S.p.A.: SWOT Overview 22
Guala Closures S.p.A.: Strengths 22
Guala Closures S.p.A.: Weaknesses 23
Guala Closures S.p.A.: Opportunities 23
Guala Closures S.p.A.: Threats 24
Guala Closures S.p.A.: Corporate Financial Deals Activity 25
Guala Closures S.p.A.: Financial Deals Overview 25
Guala Closures S.p.A.: Targets and Partners 27
Guala Closures S.p.A.: Top Deals 2014 – 2018YTD* 28
Guala Closures S.p.A.: Advisors 29
Guala Closures S.p.A.: Top Legal Advisors 29
Guala Closures S.p.A.: Top Financial Advisors 29
Guala Closures S.p.A.: Mergers and Acquisitions 30
Guala Closures S.p.A.: Private Equity and Ownership 31
Guala Closures S.p.A.: Recent Developments 32
Guala Closures S.p.A.: News and Events Summary 32
Guala Closures S.p.A.: Business Expansion 33
Guala Closures S.p.A.: Financial Deals 33
Guala Closures S.p.A.: IT Spending Announcements 33
Guala Closures S.p.A.: Market Developments 34
Guala Closures S.p.A.: Strategy and Operations 35
Appendix 36
Contact Us 36
Methodology 36
About MarketLine 37

List of Tables
Table 1: Guala Closures S.p.A.: Key Facts
Table 2: Guala Closures S.p.A.: Key Employees
Table 3: Guala Closures S.p.A.: Company History
Table 4: Guala Closures S.p.A.: Locations and Subsidiaries
Table 5: Guala Closures S.p.A.: Key Competitors
Table 6: Guala Closures S.p.A.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Guala Closures S.p.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Guala Closures S.p.A.: Targets and Partners
Table 9: Guala Closures S.p.A.: Top Deals 2014 - 2018YTD*
Table 10: Guala Closures S.p.A.: Legal Advisor Ranking by Value (US$m)
Table 11: Guala Closures S.p.A.: Financial Advisor Ranking by Value (US$m)
Table 12: Guala Closures S.p.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Guala Closures S.p.A.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Guala Closures S.p.A.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 15: Guala Closures S.p.A.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 16: Guala Closures S.p.A.: News and Events Summary
Table 17: Guala Closures S.p.A.: Business Expansion
Table 18: Guala Closures S.p.A.: Financial Deals
Table 19: Guala Closures S.p.A.: IT Spending Announcements
Table 20: Guala Closures S.p.A.: Market Developments
Table 21: Guala Closures S.p.A.: Strategy and Operations

List of Figures
Figure 1: Guala Closures S.p.A.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Guala Closures S.p.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Guala Closures S.p.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Guala Closures S.p.A.: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Guala Closures S.p.A.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 6: Guala Closures S.p.A.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Guala Closures S.p.A.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Glycotope GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Glycotope GmbH (Glycotope) is a biopharmaceutical company that develops immuno-oncology products for the treatment of various types of cancer. The company’s expression platform offers proprietary technologies such as Glycobody (GET) and GlycoExpress(GEX) that allows the glycosylation of anti …
  • Nexteer Automotive Group Ltd:企業の戦略・SWOT・財務情報
    Nexteer Automotive Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Nexteer Automotive Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • MedStar Health:企業の戦略的SWOT分析
    MedStar Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Exosome Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA p …
  • Schnell Biopharmaceuticals Inc (003060)-製薬・医療分野:企業M&A・提携分析
    Summary Schnell Biopharmaceuticals Inc (Schnell), formerly Korea Schnell Pharma Co., Ltd. is a healthcare company that offers agents and antibiotics. The company provides pharmaceutical products including amino acid infusion agents and antibiotics. Its products portfolio includes antibiotics, infusi …
  • Natural Resource Partners L.P.:企業のM&A・事業提携・投資動向
    Natural Resource Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Natural Resource Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • BioMotiv LLC-製薬・医療分野:企業M&A・提携分析
    Summary BioMotiv LLC (BioMotiv) is a development company specializes in the licensing and development of therapeutics across wide disease areas including proteins, small molecules, antibodies, and nucleotides. The company in association with The Harrington Project for Discovery & Development acceler …
  • Goodfellow Inc (GDL):企業の財務・戦略的SWOT分析
    Goodfellow Inc (GDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mitsui Fudosan Co Ltd (8801):企業の財務・戦略的SWOT分析
    Mitsui Fudosan Co Ltd (8801) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Enel Americas SA:企業の戦略・SWOT・財務分析
    Enel Americas SA - Strategy, SWOT and Corporate Finance Report Summary Enel Americas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • BlueScope Steel Ltd:企業の戦略・SWOT・財務分析
    BlueScope Steel Ltd - Strategy, SWOT and Corporate Finance Report Summary BlueScope Steel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Diagenode sa-医療機器分野:企業M&A・提携分析
    Summary Diagenode sa (Diagenode) is a provider of biological sample preparation, epigenetics research, and diagnostics assays. The company offers Bioruptor shearing and IP-star automation instruments, reagent kits, and antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. Its produ …
  • Sabine Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Sabine Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Sabine Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive informat …
  • Atlantia SpA (ATL):企業の財務・戦略的SWOT分析
    Atlantia SpA (ATL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Sinopharm Group Co Limited:企業の戦略・SWOT・財務分析
    Sinopharm Group Co Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopharm Group Co Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • China Merchants Securities Co Ltd (600999):企業の財務・戦略的SWOT分析
    China Merchants Securities Co Ltd (600999) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Vistin Pharma AS (VISTIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Vistin Pharma AS (Vistin), a subsidiary of Vistin Pharma ASA is a healthcare company that produces and supplies active pharmaceutical ingredients and solid dosage forms. The company’s products include opioids, an analgesics and antitussive; metformin, an API for the treatment of diabetes II; …
  • Multiplicom NV-医療機器分野:企業M&A・提携分析
    Summary Multiplicom NV (Multiplicom) is a molecular diagnostic company that develops, manufactures and markets genetic test kits. The company offers onco genetics, human genetics and prenatal genetics products. Its human genetics products are used for cancer genetics, genetic disorders and neurologi …
  • Snap-on Incorporated (SNA):企業の財務・戦略的SWOT分析
    Snap-on Incorporated (SNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Airbus SAS:戦略・SWOT・企業財務分析
    Airbus SAS - Strategy, SWOT and Corporate Finance Report Summary Airbus SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆